{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:39:12Z","timestamp":1791247152533,"version":"4.1.0"},"reference-count":41,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2013,8,2]],"date-time":"2013-08-02T00:00:00Z","timestamp":1375401600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0069126","type":"journal-article","created":{"date-parts":[[2013,8,2]],"date-time":"2013-08-02T21:02:36Z","timestamp":1375477356000},"page":"e69126","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":36,"title":["Nuclear Translocation of B-Cell-Specific Transcription Factor, BACH2, Modulates ROS Mediated Cytotoxic Responses in Mantle Cell Lymphoma"],"prefix":"10.1371","volume":"8","author":[{"given":"Zheng","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric F.","family":"Pittman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Romaguera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Fayad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sattva S.","family":"Neelapu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Mclaughlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larry","family":"Kwak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nami","family":"McCarty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2013,8,2]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"267","DOI":"10.3816\/CLM.2009.n.055","article-title":"Mantle cell lymphoma: biological insights and treatment advances","volume":"9","author":"JP Leonard","year":"2009","journal-title":"Clin Lymphoma Myeloma"},{"key":"ref2","first-page":"11","article-title":"Mantle cell lymphoma: from pathology and molecular pathogenesis to new therapeutic perspectives","volume":"91","author":"I Salaverria","year":"2006","journal-title":"Haematologica"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.3109\/10428190903288514","article-title":"Mantle cell lymphoma: state-of-the-art management and future perspective","volume":"50","author":"O Weigert","year":"2009","journal-title":"Leuk Lymphoma"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"5268","DOI":"10.1038\/sj.onc.1202997","article-title":"Transgenic models of lymphoid neoplasia and development of a pan-hematopoietic vector","volume":"18","author":"JM Adams","year":"1999","journal-title":"Oncogene"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"3487","DOI":"10.1002\/j.1460-2075.1994.tb06655.x","article-title":"Cyclin D1\/bcl-1 cooperates with myc genes in the generation of B-cell lymphoma in transgenic mice","volume":"13","author":"H Lovec","year":"1994","journal-title":"EMBO J"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.critrevonc.2011.05.001","article-title":"Mantle cell lymphoma","volume":"82","author":"S Cortelazzo","year":"2012","journal-title":"Crit Rev Oncol Hematol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"4867","DOI":"10.1200\/JCO.2006.07.9665","article-title":"Multicenter phase II study of bortezomib in patients with relapsed or refractory mantle cell lymphoma","volume":"24","author":"RI Fisher","year":"2006","journal-title":"J Clin Oncol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1200\/JCO.2005.03.108","article-title":"Phase II study of proteasome inhibitor bortezomib in relapsed or refractory B-cell non-Hodgkin&apos;s lymphoma","volume":"23","author":"A Goy","year":"2005","journal-title":"J Clin Oncol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1200\/JCO.2005.02.050","article-title":"Phase II clinical experience with the novel proteasome inhibitor bortezomib in patients with indolent non-Hodgkin&apos;s lymphoma and mantle cell lymphoma","volume":"23","author":"OA O'Connor","year":"2005","journal-title":"J Clin Oncol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"5291","DOI":"10.1158\/1078-0432.CCR-07-0871","article-title":"Bortezomib for the treatment of mantle cell lymphoma","volume":"13","author":"RC Kane","year":"2007","journal-title":"Clin Cancer Res"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/S0093-7754(01)90034-X","article-title":"Proteasome inhibition in cancer: development of PS-341","volume":"28","author":"J Adams","year":"2001","journal-title":"Semin Oncol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1200\/JCO.2005.11.030","article-title":"Proteasome inhibition as a novel therapeutic target in human cancer","volume":"23","author":"SV Rajkumar","year":"2005","journal-title":"J Clin Oncol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1182\/blood-2005-05-2091","article-title":"The proteasome inhibitor bortezomib induces apoptosis in mantle-cell lymphoma through generation of ROS and Noxa activation independent of p53 status","volume":"107","author":"P Perez-Galan","year":"2006","journal-title":"Blood"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/sj.leu.2404414","article-title":"Activity patterns of proteasome subunits reflect bortezomib sensitivity of hematologic malignancies and are variable in primary human leukemia cells","volume":"21","author":"M Kraus","year":"2007","journal-title":"Leukemia"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1182\/blood-2007-08-104950","article-title":"Molecular basis of bortezomib resistance: proteasome subunit beta5 (PSMB5) gene mutation and overexpression of PSMB5 protein","volume":"112","author":"R Oerlemans","year":"2008","journal-title":"Blood"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1038\/leu.2009.8","article-title":"Characterization of the ubiquitin-proteasome system in bortezomib-adapted cells","volume":"23","author":"T Ruckrich","year":"2009","journal-title":"Leukemia"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"9695","DOI":"10.1128\/MCB.24.22.9695-9704.2004","article-title":"Proteasome inhibitor PS-341 induces apoptosis through induction of endoplasmic reticulum stress-reactive oxygen species in head and neck squamous cell carcinoma cells","volume":"24","author":"A Fribley","year":"2004","journal-title":"Mol Cell Biol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"4907","DOI":"10.1182\/blood-2005-08-3531","article-title":"Proteasome inhibitors induce a terminal unfolded protein response in multiple myeloma cells","volume":"107","author":"EA Obeng","year":"2006","journal-title":"Blood"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"5101","DOI":"10.1158\/1078-0432.CCR-10-3367","article-title":"Treatment-induced oxidative stress and cellular antioxidant capacity determine response to bortezomib in mantle cell lymphoma","volume":"17","author":"MA Weniger","year":"2011","journal-title":"Clin Cancer Res"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1038\/leu.2010.137","article-title":"Bortezomib-resistant myeloma cell lines: a role for mutated PSMB5 in preventing the accumulation of unfolded proteins and fatal ER stress","volume":"24","author":"M Ri","year":"2010","journal-title":"Leukemia"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"15370","DOI":"10.1074\/jbc.275.20.15370","article-title":"Oxidative stress abolishes leptomycin B-sensitive nuclear export of transcription repressor Bach2 that counteracts activation of Maf recognition element","volume":"275","author":"H Hoshino","year":"2000","journal-title":"J Biol Chem"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"5734","DOI":"10.1093\/emboj\/17.19.5734","article-title":"Identification of Bach2 as a B-cell-specific partner for small maf proteins that negatively regulate the immunoglobulin heavy chain gene 3&apos; enhancer","volume":"17","author":"A Muto","year":"1998","journal-title":"EMBO J"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"3317","DOI":"10.1182\/blood-2002-12-3656","article-title":"B-cell-specific transcription factor BACH2 modifies the cytotoxic effects of anticancer drugs","volume":"102","author":"T Kamio","year":"2003","journal-title":"Blood"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"8012","DOI":"10.1200\/JCO.2005.02.1626","article-title":"Prognostic significance of BACH2 expression in diffuse large B-cell lymphoma: a study of the Osaka Lymphoma Study Group","volume":"23","author":"E Sakane-Ishikawa","year":"2005","journal-title":"J Clin Oncol"},{"key":"ref25","unstructured":"Jung HJ, Chen Z, Fayad L, Wang M, Romaguera J, <etal>et al<\/etal>.. (2012) Bortezomib-resistant nuclear factor kappaB expression in stem-like cells in mantle cell lymphoma. Exp Hematol 40: 107\u2013118 e102."},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.3109\/10428194.2011.562570","article-title":"Stem-like tumor cells confer drug resistant properties to mantle cell lymphoma","volume":"52","author":"HJ Jung","year":"2011","journal-title":"Leuk Lymphoma"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/bjh.12003","article-title":"Verapamil synergistically enhances cytotoxicity of bortezomib in mantle cell lymphoma via induction of reactive oxygen species production","volume":"159","author":"Z Chen","year":"2012","journal-title":"Br J Haematol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"e10391","DOI":"10.1371\/journal.pone.0010391","article-title":"Formalin-induced fluorescence reveals cell shape and morphology in biological tissue samples","volume":"5","author":"U Leischner","year":"2010","journal-title":"PLoS One"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0065-2571(84)90007-4","article-title":"Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors","volume":"22","author":"TC Chou","year":"1984","journal-title":"Adv Enzyme Regul"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.1432-1033.1981.tb06218.x","article-title":"Generalized equations for the analysis of inhibitions of Michaelis-Menten and higher-order kinetic systems with two or more mutually exclusive and nonexclusive inhibitors","volume":"115","author":"TC Chou","year":"1981","journal-title":"Eur J Biochem"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/0022-5193(76)90169-7","article-title":"Derivation and properties of Michaelis-Menten type and Hill type equations for reference ligands","volume":"59","author":"TC Chou","year":"1976","journal-title":"J Theor Biol"},{"key":"ref32","doi-asserted-by":"crossref","unstructured":"Premkumar DR, Jane EP, Agostino NR, Didomenico JD, Pollack IF (2011) Bortezomib-induced sensitization of malignant human glioma cells to vorinostat-induced apoptosis depends on reactive oxygen species production, mitochondrial dysfunction, Noxa upregulation, Mcl-1 cleavage, and DNA damage. Mol Carcinog.","DOI":"10.1002\/mc.21835"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1146\/annurev.pharmtox.46.120604.141046","article-title":"Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway","volume":"47","author":"TW Kensler","year":"2007","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1038\/nature07733","article-title":"Association of reactive oxygen species levels and radioresistance in cancer stem cells","volume":"458","author":"M Diehn","year":"2009","journal-title":"Nature"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1182\/blood-2005-12-040972","article-title":"Bcr-Abl signaling through the PI-3\/S6 kinase pathway inhibits nuclear translocation of the transcription factor Bach2, which represses the antiapoptotic factor heme oxygenase-1","volume":"109","author":"C Yoshida","year":"2007","journal-title":"Blood"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1182\/blood-2009-01-199604","article-title":"Bortezomib induces canonical nuclear factor-kappaB activation in multiple myeloma cells","volume":"114","author":"T Hideshima","year":"2009","journal-title":"Blood"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1158\/1541-7786.MCR-08-0108","article-title":"Bortezomib-resistant nuclear factor-kappaB activity in multiple myeloma cells","volume":"6","author":"S Markovina","year":"2008","journal-title":"Mol Cancer Res"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/1476-4598-7-40","article-title":"Prevalence of bortezomib-resistant constitutive NF-kappaB activity in mantle cell lymphoma","volume":"7","author":"DT Yang","year":"2008","journal-title":"Mol Cancer"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1182\/blood-2010-02-269514","article-title":"Bortezomib resistance in mantle cell lymphoma is associated with plasmacytic differentiation","volume":"117","year":"2011","journal-title":"Blood"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"3473","DOI":"10.1128\/MCB.24.8.3473-3484.2004","article-title":"Repression of PML nuclear body-associated transcription by oxidative stress-activated Bach2","volume":"24","author":"S Tashiro","year":"2004","journal-title":"Mol Cell Biol"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1038\/35066075","article-title":"Chromosome territories, nuclear architecture and gene regulation in mammalian cells","volume":"2","author":"T Cremer","year":"2001","journal-title":"Nat Rev Genet"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0069126","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,20]],"date-time":"2019-07-20T09:15:29Z","timestamp":1563614129000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0069126"}},"subtitle":[],"editor":[{"given":"Jose Angel Martinez","family":"Climent","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2013,8,2]]},"references-count":41,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2013,8,2]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0069126","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,8,2]]}}}